Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 93, A61K 3144, C07D40104, C07D40114

Patent

active

059454300

ABSTRACT:
Novel aminooxyamide tricyclic compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide tricyclic compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammals such as a human.

REFERENCES:
patent: 5438062 (1995-08-01), Piwinski et al.
patent: 5665726 (1997-09-01), Piwinski et al.
patent: 5696121 (1997-12-01), Bishop
Khosravi-Far R et al. Cell Growth & Differentiation. 3, 461-9, Jul. 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2426591

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.